102 related articles for article (PubMed ID: 24876523)
1. p57(Kip2) regulates T-cell development and lymphoma.
Jayapal SR; Kaldis P
Blood; 2014 May; 123(22):3370-1. PubMed ID: 24876523
[No Abstract] [Full Text] [Related]
2. p57 regulates T-cell development and prevents lymphomagenesis by balancing p53 activity and pre-TCR signaling.
Matsumoto A; Takeishi S; Nakayama KI
Blood; 2014 May; 123(22):3429-39. PubMed ID: 24652995
[TBL] [Abstract][Full Text] [Related]
3. Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.
Nan KJ; Guo H; Ruan ZP; Jing Z; Liu SX
World J Gastroenterol; 2005 Feb; 11(8):1237-40. PubMed ID: 15754413
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of the p57-E2F1-p53 axis results in nonobstructive hydrocephalus and cerebellar malformation in mice.
Matsumoto A; Susaki E; Onoyama I; Nakayama K; Hoshino M; Nakayama KI
Mol Cell Biol; 2011 Oct; 31(20):4176-92. PubMed ID: 21844226
[TBL] [Abstract][Full Text] [Related]
5. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues.
Fan GK; Xu F; Yang B; Fujieda S
Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659
[TBL] [Abstract][Full Text] [Related]
6. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
Vlachos P; Joseph B
Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
[TBL] [Abstract][Full Text] [Related]
7. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
8. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients.
Biaoxue R; Xiguang C; Hua L; Hui M; Shuanying Y; Wei Z; Wenli S; Jie D
Int J Biol Markers; 2011; 26(1):9-21. PubMed ID: 21360479
[TBL] [Abstract][Full Text] [Related]
12. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract][Full Text] [Related]
13. Expression of p57-Kip2 in monocytes and macrophages.
Hofer TP; Frankenberger M; Staples KJ; Ziegler-Heitbrock L
Immunobiology; 2006; 211(6-8):455-62. PubMed ID: 16920485
[TBL] [Abstract][Full Text] [Related]
14. The hallmarks of CDKN1C (p57, KIP2) in cancer.
Kavanagh E; Joseph B
Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
[TBL] [Abstract][Full Text] [Related]
15. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
[TBL] [Abstract][Full Text] [Related]
16. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.
Vlachos P; Nyman U; Hajji N; Joseph B
Cell Death Differ; 2007 Aug; 14(8):1497-507. PubMed ID: 17464323
[TBL] [Abstract][Full Text] [Related]
17. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression.
Beverly LJ; Felsher DW; Capobianco AJ
Cancer Res; 2005 Aug; 65(16):7159-68. PubMed ID: 16103066
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
[TBL] [Abstract][Full Text] [Related]
19. High Dosage Lithium Treatment Induces DNA Damage and p57
Stampone E; Bencivenga D; Barone C; Aulitto A; Verace F; Della Ragione F; Borriello A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050593
[TBL] [Abstract][Full Text] [Related]
20. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts.
Takahashi K; Kobayashi T; Kanayama N
Mol Hum Reprod; 2000 Nov; 6(11):1019-25. PubMed ID: 11044465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
